Altered G6PD activity is associated with lipid dysregulation, insulin resistance, increased body weight, and obesity since G6PD is the common player in glycolysis, gluconeogenesis, lipid metabolism PPP, and oxidative stress. This evidence concerns the gene G6PD and obesity due to melanocortin 4 receptor deficiency.